Good practice and quality assurance in surgical oncology

被引:15
作者
Douek, M [1 ]
Taylor, I [1 ]
机构
[1] UCL, Royal Free & Univ Coll Med Sch, Dept Surg, London W1W 7EJ, England
关键词
D O I
10.1016/S1470-2045(03)01222-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The Halstedian era of radical surgical extirpation for solid tumours dominated the first half of the 20th century. But as understanding of cancer biology increased, a paradigm shift occured which moved the focus away from extensive surgery towards less radical procedures. Although surgery is a recognised factor in local disease control, prognosis is now believed to be predetermined at the time of diagnosis by the presence of micrometastatic deposits. Modern cancer management consists of more skilled and conservative surgery to remove the primary tumour; adjuvant therapies are also given before and after the operation to target the subclinical metastatic deposits. The most important components of high-quality care in surgical oncology are: sound clinical judgment, surgical skill, and multidisciplinary care. These prerequisites are best achieved by specialisation, but high operative volume is not essential for excision of many types of tumour. Quality assurance using several readily available tools can ensure that the process of care from presentation to outcome is constantly improved and that institutional variations in number of cases and quality of care are monitored.
引用
收藏
页码:626 / 630
页数:5
相关论文
共 46 条
[1]
PROGNOSTIC FACTORS IN UNSELECTED PATIENTS WITH NONSEMINOMATOUS METASTATIC TESTICULAR CANCER - A MULTICENTER EXPERIENCE [J].
AASS, N ;
KLEPP, O ;
CAVALLINSTAHL, E ;
DAHL, O ;
WICKLUND, H ;
UNSGAARD, B ;
BALDETORP, L ;
AHLSTROM, S ;
FOSSA, SD .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (05) :818-826
[2]
ROLE OF CIRCUMFERENTIAL MARGIN INVOLVEMENT IN THE LOCAL RECURRENCE OF RECTAL-CANCER [J].
ADAM, IJ ;
MOHAMDEE, MO ;
MARTIN, IG ;
SCOTT, N ;
FINAN, PJ ;
JOHNSTON, D ;
DIXON, MF ;
QUIRKE, P .
LANCET, 1994, 344 (8924) :707-711
[3]
Chaudhry R, 2001, CAN MED ASSOC J, V164, P183
[4]
Sentinel node biopsy in breast cancer: ALMANAC trial [J].
Clarke, D ;
Khonji, NI ;
Mansel, RE .
WORLD JOURNAL OF SURGERY, 2001, 25 (06) :819-822
[5]
DAVIS S, 1987, JNCI-J NATL CANCER I, V78, P471
[6]
*DEP HLTH, 2002, HOSP EP STAT
[7]
Douek M, 2003, BRIT J SURG, V90, P44
[8]
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials [J].
Early Breast Cancer Trialists' Collaborative Group .
LANCET, 2000, 355 (9217) :1757-1770
[9]
EDGE SB, 1993, CANCER-AM CANCER SOC, V71, P3502, DOI 10.1002/1097-0142(19930601)71:11<3502::AID-CNCR2820711107>3.0.CO
[10]
2-N